Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

India To Cap Profit Margins On Drugs

by K. V. Venkatasubramanian
January 25, 2016 | A version of this story appeared in Volume 94, Issue 4

[+]Enlarge
Credit: Paul Prescott/Shutterstock
India’s government is planning to curb markups on pharmaceuticals.
Photo shows pharmacy assistant selling medicine to customers in Delhi, India.
Credit: Paul Prescott/Shutterstock
India’s government is planning to curb markups on pharmaceuticals.

Drug prices in India are expected to soon fall significantly with the central government planning to put a ceiling on the profit margins of retail pharmacies and wholesalers at 35%. The move, which follows recommendations of an expert committee constituted under the Department of Pharmaceuticals, is expected to benefit consumers. Pharmacies and wholesalers allegedly charge 400–500% margins on drugs that are already steeply priced. The government is attempting to restrict that percentage and ensure that vital drugs are available at affordable prices. Shobha Mishra Ghosh, senior director of the Federation of Indian Chambers of Commerce & Industry, India’s oldest business organization, says it is difficult to determine whether the move could impact imports of drugs into the country. Ghosh represented the federation on the expert committee.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.